
Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer
Keywords: پروستات; Prostate; Prostatic neoplasms; Adjuvant androgen deprivation therapy; LHRH agonists; SEER-Medicare; Instrumental variables;